| scholarly article | Q13442814 |
| P2093 | author name string | Chrispin Kambili | |
| Abela Mpobela Agnarson | |||
| Amit Dhir | |||
| Laurent Metz | |||
| Ravi Potluri | |||
| Hitesh Bhandari | |||
| Xiao Chun Wang | |||
| P2860 | cites work | The diarylquinoline TMC207 for multidrug-resistant tuberculosis | Q28247333 |
| Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration | Q28275843 | ||
| Bedaquiline: First FDA-approved tuberculosis drug in 40 years | Q28293046 | ||
| Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation | Q28536653 | ||
| Drug-resistant tuberculosis control in China: progress and challenges | Q30386148 | ||
| Multidrug-resistant tuberculosis and culture conversion with bedaquiline. | Q34434294 | ||
| Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries. | Q36260334 | ||
| Implementation and community involvement in DOTS strategy: a systematic review of studies in China | Q38050288 | ||
| Bedaquiline: a new hope for shorter and better anti-tuberculosis regimens | Q38669764 | ||
| Endogenous reactivation followed by exogenous re-infection with drug resistant strains, a new challenge for tuberculosis control in Saudi Arabia | Q38866256 | ||
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. | Q38915347 | ||
| Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. | Q38969662 | ||
| Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience | Q39044074 | ||
| Assessment of tuberculosis burden in China using a dynamic disease simulation model | Q39390692 | ||
| Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China | Q40088506 | ||
| Tuberculosis transmission and risk factors in a Chinese antimony mining community | Q40187783 | ||
| Exogenous reinfection of tuberculosis in a low-burden area. | Q41441140 | ||
| Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries | Q46202128 | ||
| The burden and challenges of tuberculosis in China: findings from the Global Burden of Disease Study 2015. | Q47227595 | ||
| LONG TERM BEDAQUILINE-RELATED TREATMENT OUTCOMES IN PATIENTS WITH EXTENSIVELY DRUG RESISTANT TUBERCULOSIS FROM SOUTH AFRICA. | Q53691085 | ||
| High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen | Q58555696 | ||
| Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study | Q90005307 | ||
| Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis | Q91184751 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 113 | |
| P577 | publication date | 2020-02-10 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China | |
| P478 | volume | 20 |
Search more.